P3 Health Partners Stock Alpha and Beta Analysis
| PIII Stock | USD 0.21 0 1.43% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as P3 Health Partners. It also helps investors analyze the systematic and unsystematic risks associated with investing in P3 Health over a specified time horizon. Remember, high P3 Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to P3 Health's market risk premium analysis include:
Beta 2.21 | Alpha (1.19) | Risk 8.1 | Sharpe Ratio (0.13) | Expected Return (1.03) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PIII |
P3 Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. P3 Health market risk premium is the additional return an investor will receive from holding P3 Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in P3 Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate P3 Health's performance over market.| α | -1.19 | β | 2.21 |
P3 Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of P3 Health's Buy-and-hold return. Our buy-and-hold chart shows how P3 Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.P3 Health Market Price Analysis
Market price analysis indicators help investors to evaluate how P3 Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading P3 Health shares will generate the highest return on investment. By understating and applying P3 Health stock market price indicators, traders can identify P3 Health position entry and exit signals to maximize returns.
P3 Health Return and Market Media
The median price of P3 Health for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 is 0.39 with a coefficient of variation of 21.57. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 0.4, and mean deviation of 0.07. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4883 subject to Rule 16b-3 | 09/04/2024 |
2 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4898 subject to Rule 16b-3 | 09/06/2024 |
3 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.5591 subject to Rule 16b-3 | 09/11/2024 |
4 | SHAREHOLDER ALERT Levi Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc. | 09/23/2024 |
5 | Insider Trading | 10/01/2024 |
6 | SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Partners, Inc. | 10/10/2024 |
7 | SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc. | 10/14/2024 |
8 | SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partners | 10/29/2024 |
9 | Acquisition by Erin Darakjian of 100000 shares of P3 Health subject to Rule 16b-3 | 11/05/2024 |
10 | What To Expect From P3 Health Partners Inc Q3 2024 Earnings | 11/11/2024 |
11 | P3 Health Partners Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
12 | P3 Health Partners Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags | 11/15/2024 |
13 | Acquisition by Bacchus Amir of 1000000 shares of P3 Health subject to Rule 16b-3 | 11/19/2024 |
14 | TD Cowen Lowers P3 Health Partners Price Target to 0.25 | 11/21/2024 |
About P3 Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PIII or other stocks. Alpha measures the amount that position in P3 Health Partners has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 5.99 | 4.54 | 4.53 | 3.22 | Receivables Turnover | 9.6K | 13.19 | 10.43 | 9.9 |
P3 Health Upcoming Company Events
As portrayed in its financial statements, the presentation of P3 Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, P3 Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of P3 Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of P3 Health. Please utilize our Beneish M Score to check the likelihood of P3 Health's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with P3 Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out P3 Health Backtesting, P3 Health Valuation, P3 Health Correlation, P3 Health Hype Analysis, P3 Health Volatility, P3 Health History and analyze P3 Health Performance. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
P3 Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.